Outline of presentation. Pinyo Rattanaumpawan; Sajja Supornpun; Basic Concepts of ASP Research to Practice in ASP ASP Siriraj

Size: px
Start display at page:

Download "Outline of presentation. Pinyo Rattanaumpawan; Sajja Supornpun; Basic Concepts of ASP Research to Practice in ASP ASP Siriraj"

Transcription

1 1 Pinyo Rattanaumpawan; MD, MSCE, PhD Division of Infectious Diseases and Tropical Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University Sajja Supornpun; BPharm, MS Department of Pharmacy, Faculty of Medicine Siriraj Hospital, Mahidol University Outline of presentation Basic Concepts of ASP Research to Practice in ASP ASP Siriraj

2 2 What is ASP? ASP is a key component of multifaceted approach to preventing emergence of antimicrobial resistance (AMR) ASP strategies 1. Education/Guidelines 2. Formulary/Restriction 3. Review and feedback 4. Computer assistance 5. Antimicrobial cycling

3 1. Education/Guidelines Procedure: Creation of guidelines for antimicrobial use Group or individual education of clinicians by educators Personnel: Antimicrobial committee to create the guidelines Educators Advantages: May alter behavior pattern Avoid loss of autonomy Disadvantage: Less effective 2. Formulary/Restriction Procedure: Restrict dispensing of targeted antibiotics to approved indications Personnel: Antimicrobial committee to create the formulary Approval personnel Advantages: Most direct control over antimicrobial use Individual educational opportunities Disadvantage: Perceived loss of autonomy Need for all-hours consultant availability 3

4 4 3. Review and feedback Procedure: Review of targeted antibiotics for appropriateness Contact prescribers with recommendation Personnel: ASP committee to create the guidelines Review personnel (usually clinical pharmacists) Advantages: Avoid loss of autonomy Individual educational opportunities Disadvantage: Less effective 4. Computer Assistance Procedure: The system will provide individual recommendation at point of care Personnel: Antimicrobial committee to create the IT system Review personnel and computer program Advantages: Provides individual recommendation Facilitates other strategies Disadvantage: Need sophisticated system Significant time and resource investment

5 5 5. Antibiotic Cycling Procedure: Scheduled rotation of antibiotic used in hospital or unit Personnel: Antimicrobial committee to create protocol Personnel to oversee adherence Advantages: May reduce resistance by changing selective pressure Disadvantage: Might not effective (difficult to ensure adherence to cycling protocol) Building The Team Hospital Administrators Infectious Diseases Specialists Infection Control Clinical Pharmacists Antimicrobial Stewardship Microbiologist OR Personnel Surgical Infection Experts/Surgeons Pulmonologist/ Intensivist

6 6 Building The Team General Practitioner Hospital Administrators Clinical Pharmacists Antimicrobial Stewardship OR Personnel ASP Endpoints Clinical and Economic outcomes Antibiotic consumption: Defined daily dose (DDD) or Day of Therapy (DOT) DDD of antibiotic-x = Total amount of antibiotic-x used WHO assigned DDD of antibiotic-x DOT of antibiotic-x = Total duration of antibiotic-x use Example - Levofloxacin WHO DDD = 500 mg/d Total amount used = 750 mgx10 day = 7500 mg DDD = 7500/500 = 15 DOTs = 10 days Polk RE. CID 2007;44:664-70

7 7 DDD vs. DOTs DDD underestimates antibiotic exposure in Patients with impaired renal function Pediatric patients Polk RE. CID 2007;44: Outline of presentation Basic Concepts of ASP Research to Practice in ASP ASP Siriraj

8 8 Update from 2016 IDSA/SHEA guideline for ASP Implementation Recommendations: Preauthorization/prospective audit and feedback Incorporate computer systems PK dosing vancomycin, aminoglycoside Alternate ceph dosing strategies to reduce cost IV-to-PO switching Guideline for Implementing an Antibiotic Stewardship Program CID 2016 Update from 2016 IDSA/SHEA guideline for ASP Implementation Recommendations (c0nt.): Shortening duration Development of stratified antibiogram to assist ASPs in developing ATB guideline for empirical therapy Selective and cascade reporting of ATB (not report all ATBs tested) Guideline for Implementing an Antibiotic Stewardship Program CID 2016

9 9 Update from 2016 IDSA/SHEA guideline for ASP Implementation Recommendations (cont.): Rapid test for viral, serial PCT, non culture based fungal marker DOTs instead of DDD Costs should be measured based on administration costs not purchasing cost Syndrome specific monitoring Guideline for Implementing an Antibiotic Stewardship Program CID 2016 Update from 2016 IDSA/SHEA guideline for ASP Implementation Against: X ONLY didactic educational materials X Antibiotic cycling Guideline for Implementing an Antibiotic Stewardship Program CID 2016

10 Pre-prescription-authorization (PPA) vs. Post-pres. Review & feedback (PPRF) A quasi-experimental, crossover trial comparing PPA and PPRF for adult inpatients at John Hopkins hospital ASP by ID-trained clinicians (based on hosp. guideline) PPA DOT PPRF Clinical Infectious Diseases 2017;64(5): Impact of a Hospital-Based Antimicrobial Management Program on Clinical and Economic Outcomes A study conducted at a tertiary care hospital ID-clinical pharmacists (AMT) vs. ID-fellows ID-specialists decision: gold standard The AMT team outperformed the ID fellows Appropriateness [87% vs. 47%; P =0.001] Cure rate [64% vs. 42%; P=0.007] Treatment failures [15% vs. 28%; P=0.03] No difference in cost saving Gross, R. et al. CID 2001;33:

Surgical antibiotic prophylaxis at Epworth Healthcare

Surgical antibiotic prophylaxis at Epworth Healthcare Surgical antibiotic prophylaxis at Epworth Healthcare Dr Joseph Doyle MPH PhD FRACP Infectious Diseases Physician Epworth, Alfred Health & Melbourne Health Senior Lecturer & NHMRC Clinical Research Fellow,

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2 Journal of Pharmacy and Pharmacology 5 (2017) 607-615 doi: 10.17265/2328-2150/2017.09.001 D DAVID PUBLISHING Comparative Evaluation of Pharmacist-Managed Vancomycin Dosing in a Community Hospital Following

More information

Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System

Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System Kelly Goodson, PharmD; Erin Roach, Pharmd; Susan Bear, PharmD; Lisa Davidson, MD Carolinas HealthCare System is one of

More information

Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016

Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016 Adult Inpatient Antibiogram Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates January to December 2016 Department of Pathology Camille Hamula, PhD Director, Clinical Microbiology

More information

Outline. Pharmacists Improving Outcomes in the Management of. of Infectious Diseases. Threats Against Desired Outcomes 7/11/2010

Outline. Pharmacists Improving Outcomes in the Management of. of Infectious Diseases. Threats Against Desired Outcomes 7/11/2010 Pharmacists Improving Outcomes in the Management of Infectious Diseases Christine Teng, MSc(Clin Pharm) BCPS Assistant Professor Dept of Pharmacy, National University of Singapore Principal Pharmacist

More information

MONTEFIORE MEDICAL CENTER

MONTEFIORE MEDICAL CENTER DEPARTMENT OF PHARMACY MONTEFIORE MEDICAL CENTER SUBJECT: MANUAL CODE: Restricted Drugs Policy, Antibiotic Restriction PH-R-5 DATE ISSUED: August, 1976 DATE REVISED: September 2000, October 2003, September

More information

Faculty Advisors: Catherine O Brien, PharmD and Holly Maples, PharmD Location: Arkansas Children s Hospital

Faculty Advisors: Catherine O Brien, PharmD and Holly Maples, PharmD Location: Arkansas Children s Hospital Faculty Advisors: Catherine O Brien, PharmD and Holly Maples, PharmD Location: Arkansas Children s Hospital 2010 Pharmacy Practice Student Research Fellowship Title: Evaluation of Vancomycin Pharmacokinetics

More information

Infectious Diseases Pharmacy Content Outline June 2017

Infectious Diseases Pharmacy Content Outline June 2017 Infectious Diseases Pharmacy Content Outline June 2017 The following domains, tasks and knowledge statements were delineated by the BPS Infectious Disease Pharmacy Practice Analysis Taskforce and validated

More information

Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department

Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department Dr. Eugene Tso Division of Infectious Diseases Department of Medicine & Geriatrics United Christian Hospital 11 May 2010

More information

IMPLEMENTING ANTIMICROBIAL STEWARDSHIP IN A CRITICAL ACCESS HOSPITAL

IMPLEMENTING ANTIMICROBIAL STEWARDSHIP IN A CRITICAL ACCESS HOSPITAL IMPLEMENTING ANTIMICROBIAL STEWARDSHIP IN A CRITICAL ACCESS HOSPITAL The nitty gritty of a practical approach. Cameale Johnson, PharmD MBA South Peninsula Hospital Homer, Alaska What this presentation

More information

OPAT FOR INFECTION IN BRONCHIECTASIS

OPAT FOR INFECTION IN BRONCHIECTASIS OPAT FOR INFECTION IN BRONCHIECTASIS AN AUDIT EVALUATING THE USAGE OF OUTPATIENT ANTIBIOTIC THERAPY FOR INFECTIVE EXACERBATIONS OF BRONCHIECTASIS AGAINST CURRENT BRITISH THORACIC SOCIETY GUIDELINES Dr

More information

Tomasz Z. Jodlowski, Pharm.D., BCPS (AQ-ID) Clinical Pharmacy Specialist, Infectious Diseases VA North Texas HCS

Tomasz Z. Jodlowski, Pharm.D., BCPS (AQ-ID) Clinical Pharmacy Specialist, Infectious Diseases VA North Texas HCS Tomasz Z. Jodlowski, Pharm.D., BCPS (AQ-ID) Clinical Pharmacy Specialist, Infectious Diseases VA North Texas HCS Tomasz.Jodlowski@va.gov 02/06/2018 Independent contractor. IPRO. IPRO Antibiotic Stewardship

More information

University of Groningen. Impact of medical microbiology Dik, Jan-Willem

University of Groningen. Impact of medical microbiology Dik, Jan-Willem University of Groningen Impact of medical microbiology Dik, Jan-Willem IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the

More information

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments March 3, 2010 To: Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Bureau of Healthcare Associated Infections HEALTH ADVISORY: GUIDANCE FOR PREVENTION AND CONTROL OF HEALTHCARE

More information

MALDI-TOF MS: Translating Microbiology Laboratory Alphabet Soup to Optimize Antibiotic Therapy

MALDI-TOF MS: Translating Microbiology Laboratory Alphabet Soup to Optimize Antibiotic Therapy MALDI-TOF MS: Translating Microbiology Laboratory Alphabet Soup to Optimize Antibiotic Therapy September 8, 2017 Amy Carr, PharmD PGY-2 Infectious Diseases Pharmacy Resident Seton Healthcare Family amy.carr@ascension.org

More information

Dr Una Ni Riain, Consultant Microbiologist Ms Marie Tierney, Antimicrobial Pharmacist Galway University Hospitals

Dr Una Ni Riain, Consultant Microbiologist Ms Marie Tierney, Antimicrobial Pharmacist Galway University Hospitals Dr Una Ni Riain, Consultant Microbiologist Ms Marie Tierney, Antimicrobial Pharmacist Galway University Hospitals Background Usage of meropenem in our hospital has doubled over the past seven years from

More information

Disclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice

Disclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice Procalcitonin: Pearls and Pitfalls in Daily Practice Sarah K Harrison, PharmD, BCCCP Clinical Pearl Disclosures The author of this presentation has no disclosures concerning possible financial or personal

More information

GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS

GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS Version 3.0 Date ratified May 2008 Review date May 2010 Ratified by NUH Antibiotic Guidelines Committee NUH Drugs and Therapeutics

More information

Addressing Medication Errors in HIV-Positive Inpatients: A Clinician s Guide to Assessing Antiretroviral Therapy

Addressing Medication Errors in HIV-Positive Inpatients: A Clinician s Guide to Assessing Antiretroviral Therapy Addressing Medication Errors in HIV-Positive Inpatients: A Clinician s Guide to Assessing Antiretroviral Therapy Emily Li, BScPharm, PharmD Candidate 1 Elliot Pittman, BScPharm, PharmD Candidate 1 Michelle

More information

Antimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections

Antimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections Antimicrobial Guidelines for the Empirical Management of Diabetic Foot Infections Version 7.2 PAGL Inclusion Approved at January 2017 PGC APPROVED BY: TRUST REFERENCE: B3/2017 AWP REF: UHL Policies and

More information

To develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion.

To develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion. Page 1 of 5 TITLE: COMMUNITY-ACQUIRED PNEUMONIA (CAP) EMPIRIC MANAGEMENT OF ADULT PATIENTS AND IV TO PO CONVERSION GUIDELINES: These guidelines serve to aid clinicians in the diagnostic work-up, assessment

More information

Addressing Today s Challenging Bacterial Infections: Expert Views on Treatment Paradigms

Addressing Today s Challenging Bacterial Infections: Expert Views on Treatment Paradigms Addressing Today s Challenging Bacterial Infections: Expert Views on Treatment Paradigms Symposium Outcomes Report Merck Grant ID: AAN-180403-047752 Overview Activity Description: This symposium provided

More information

Medication Adherence

Medication Adherence Medication Adherence 1-30-15 Presented by: Alexander Luong, Pharm.D. Candidate 2015 University of the Pacific Preceptor: Dr. Craig Stern Pharm.D., MBA President Pro Pharma Pharmaceutical Consultants, Inc

More information

Update on Antifungal Stewardship

Update on Antifungal Stewardship Update on Antifungal Stewardship Dr Jacqueline Sneddon, MRPharmS Scottish Antimicrobial Prescribing Group Antimicrobial Management Team event 7 th November 2017 ANTIFUNGAL STEERING GROUP CHAIR Prof Brian

More information

PPP 1. Continuation, modification, and discontinuation of a medication

PPP 1. Continuation, modification, and discontinuation of a medication PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The

More information

Responders as percent of overall members in each category: Practice: Adult 537 (51% of 1063 members) 23 (59% of 39 members)

Responders as percent of overall members in each category: Practice: Adult 537 (51% of 1063 members) 23 (59% of 39 members) Infectious Diseases Society of America Emerging Infections Network Report for Query: Antibiotic Allergies and Infectious Disease Practice Overall response rate: 744/1411 (52.7%) physicians responded from

More information

Background. Background. Background 3/14/2014. Conflict of Interest Statement:

Background. Background. Background 3/14/2014. Conflict of Interest Statement: Platform Presentations Comparison of zolpidem to other drugs associated with falls in hospitalized patients Ed Rainville, MSPharm. Conflict of Interest Statement: The speaker has no conflict of interest

More information

Antimicrobial Stewardship and Urinary Tract Infections

Antimicrobial Stewardship and Urinary Tract Infections Antimicrobial Stewardship and Urinary Tract Infections Samantha Loutzeheiser, PharmD, BCPS Andrea Pallotta, PharmD, BCPS (AQ-ID), AAHIVP Cleveland Clinic Medina Hospital Cleveland Clinic Main Campus Objectives

More information

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer Journey to Decreasing Clostridium Difficile and the Unexpected Twist Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer 4/13/2018 Objectives Discuss the organism and clinical

More information

Drug Use Indicators. Dr Olayinka Ogunleye Consultant Physician/Clinical Pharmacologist Department of Medicine, LASUTH, Ikeja, LAGOS

Drug Use Indicators. Dr Olayinka Ogunleye Consultant Physician/Clinical Pharmacologist Department of Medicine, LASUTH, Ikeja, LAGOS Drug Use Indicators Dr Olayinka Ogunleye Consultant Physician/Clinical Pharmacologist Department of Medicine, LASUTH, Ikeja, LAGOS 1 Background WHO (1995) Conference on Rational Use of Drugs in Nairobi

More information

Investigators Meeting

Investigators Meeting Outcomes of Urinary Tract Infection Management by Pharmacists (R x OUTMAP) Investigators Meeting June 11, 2017 Overview 1. Introductions and Opening Remarks 2. Epidemiology and Definitions 3. UTI Assessment

More information

IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE:

IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE: IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE: IMPACT OF A PHARMACY DEPARTMENT-WIDE APPROACH IN A COMMUNITY HOSPITAL SETTING November 2014 Monica Dorobisz,

More information

Evelina London Children s Hospital (ELCH)

Evelina London Children s Hospital (ELCH) Evelina London Children s Hospital (ELCH) Lead Consultant Jenny Handforth PID Pharmacist Faye Chappell Paediatric OPAT CNS Vacant Overview Paediatric OPAT in London Paediatric OPAT ELCH Children s Hospital

More information

October 24, 2018 Produced and Edited by: Gregory K. Perry, PharmD, BCPS-AQID Pharmacy Clinical Manager

October 24, 2018 Produced and Edited by: Gregory K. Perry, PharmD, BCPS-AQID Pharmacy Clinical Manager VOLUME FOUR; ISSUE 8 October 24, 2018 Produced and Edited by: Gregory K. Perry, PharmD, BCPS-AQID Pharmacy Clinical Manager InPHARMation Pharmacy and Therapeutics Committee Update October 24 th, 2018 Meeting

More information

Impact of an Antimicrobial Stewardship Program on Unnecessary Double Anaerobic Coverage Prescription

Impact of an Antimicrobial Stewardship Program on Unnecessary Double Anaerobic Coverage Prescription Original Article http://dx.doi.org/10.3947/ic.2015.47.2.111 Infect Chemother 2015;47(2):111-116 ISSN 2093-23 (Print) ISSN 2092-6448 (Online) Infection & Chemotherapy Impact of an Antimicrobial Stewardship

More information

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job

More information

Role of the Clinical Pharmacist in Primary Care

Role of the Clinical Pharmacist in Primary Care Role of the Clinical Pharmacist in Primary Care Amy Kramer, Pharm.D., Manager Clinical Pharmacy Services Kaiser Permanente Holly Miller, Pharm.D., BCACP, Primary Care Clinical Pharmacist Kaiser Permanente

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Microbiological evaluation: how to report the results Alvaro Pascual MD, PhD Infectious Diseases and Clinical Microbiology Unit. University Hospital Virgen Macarena University of Sevilla BSI management

More information

Annual Surveillance Summary: Vancomycin- Resistant Enterococci (VRE) Infections in the Military Health System (MHS), 2016

Annual Surveillance Summary: Vancomycin- Resistant Enterococci (VRE) Infections in the Military Health System (MHS), 2016 Annual Surveillance Summary: Vancomycin- Resistant Enterococci (VRE) Infections in the Military Health System (MHS), 2016 Kristen Rossi and Uzo Chukwuma Approved for public release. Distribution is unlimited.

More information

Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy

Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy MAJOR ARTICLE Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy Ronald E. Polk, 1 Christina Fox, 1 Anne Mahoney, 2 Jim Letcavage, 2 and

More information

NHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary

NHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary Directorate for Health and Social Care Integration Primary Care NHS Circular: abcdefghijklmnopqrstu Dear Colleague LIST OF DRUGS SUBJECT TO PRESCRIBING TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH

More information

Family Medicine Clinical Pharmacy Forum Vol. 3, Issue 1 (January/February 2007)

Family Medicine Clinical Pharmacy Forum Vol. 3, Issue 1 (January/February 2007) 1 Family Medicine Clinical Pharmacy Forum Vol. 3, Issue 1 (January/February 2007) Family Medicine Clinical Pharmacy Forum is a brief bi-monthly publication from the Family Medicine clinical pharmacists

More information

MidCentral District Health Board Rheumatic Fever Prevention Plan. October 2013

MidCentral District Health Board Rheumatic Fever Prevention Plan. October 2013 MidCentral District Health Board Rheumatic Fever Prevention Plan October 2013 Contents Section 1: Introduction... 3 1.1 Executive summary... 3 1.2 Purpose... 5 Section 2: Overview of acute rheumatic fever

More information

English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset

English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset The 5-year UK AMR strategy Key aims improving infection prevention and control practices optimising

More information

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining

More information

Interventions and innovations at community level to improve antibiotic access and use: global overview

Interventions and innovations at community level to improve antibiotic access and use: global overview Interventions and innovations at community level to improve antibiotic access and use: global overview Kathleen Holloway Regional Advisor Essential Drugs and Other Medicines WHO South East Asia Regional

More information

Antimicrobial Stewardship in Community Acquired Pneumonia

Antimicrobial Stewardship in Community Acquired Pneumonia Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis

More information

Learning Objectives. A Critical Analysis of Recent Fidaxomicin & Nesiritide Trials. Fidaxomicin vs. Vancomycin. Outline 1/3/2012

Learning Objectives. A Critical Analysis of Recent Fidaxomicin & Nesiritide Trials. Fidaxomicin vs. Vancomycin. Outline 1/3/2012 Learning Objectives A Critical Analysis of Recent Fidaxomicin & Nesiritide Trials Amy E. Lodolce, PharmD, BCPS Assistant Director, Drug Information Group UIC College of Pharmacy Describe the methods and

More information

Follow this and additional works at:

Follow this and additional works at: Regis University epublications at Regis University Celebration of Scholarship and Research Center for Scholarship and Research Engagement Spring -11-17 Implementation of education with ongoing feedback

More information

NHS West Cheshire Clinical Commissioning Group does not fund the prescribing for dental conditions on FP10.

NHS West Cheshire Clinical Commissioning Group does not fund the prescribing for dental conditions on FP10. PRESCRIBING COMMISSIONING POLICY: DENTAL CONDITIONS NHS West Cheshire Clinical Commissioning Group does not fund the prescribing for dental conditions on FP10. Note: Patients who are not eligible for treatment

More information

Community Acquired & Nosocomial Pneumonias

Community Acquired & Nosocomial Pneumonias Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP

More information

Clinical Safety & Effectiveness Cohort # 10

Clinical Safety & Effectiveness Cohort # 10 1 Clinical Safety & Effectiveness Cohort # 10 Improving Weight-Based Vancomycin Dosing and Monitoring DATE Educating for Quality Improvement & Patient Safety 2 Financial Disclosure lizabeth A. Walter,

More information

2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members

2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members 2012 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2012 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program

More information

Medicines regulation - National

Medicines regulation - National Medicines regulation - National David Legge Savar, November 2018 (Several slides from Ken Harvey gratefully acknowledged) 1 National regulation Licensing of manufacturers and certification of foreign manufacture

More information

See reverse side for important facts about how to save on your prescriptions.

See reverse side for important facts about how to save on your prescriptions. The University of Akron Benefits Administration Akron, OH 44325-4704 > 001 P50708 _PM 6088 GROUP JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 Use your card to save on prescriptions. Because saving

More information

Prudhivi Ramakrishna et al / Int. J. Res. Ayurveda Pharm. 7(Suppl 4), Sep Oct Research Article.

Prudhivi Ramakrishna et al / Int. J. Res. Ayurveda Pharm. 7(Suppl 4), Sep Oct Research Article. Research Article www.ijrap.net MONITORING OF PRESCRIPTION PATTERN OF ANTIMICROBIAL AGENTS IN MEDICINE DEPARTMENT OF A TERTIARY CARE HOSPITAL Prudhivi Ramakrishna * 1, Maddi Ramaiah 2, Krishna Pavan Kumar

More information

Joint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics

Joint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics A clinical guideline recommended For use in: All clinical areas where vancomycin is prescribed for Children aged 1 month to 16 years By: All medical, nursing, pharmacy, microbiology and phlebotomy paediatric

More information

Amy-Jo Hooley Specialist Clinical Pharmacist

Amy-Jo Hooley Specialist Clinical Pharmacist Gut Decontamination Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the Safe Administration

More information

ZIN EN ONZIN VAN ANTIBIOTICASPIEGELS BIJ NEONATEN

ZIN EN ONZIN VAN ANTIBIOTICASPIEGELS BIJ NEONATEN ZIN EN ONZIN VAN ANTIBIOTICASPIEGELS BIJ NEONATEN Anne Smits Fellow neonatologie UZ Leuven Use of antibiotics in neonates 50 European hospitals 23 non-european hospitals Countries n = 14 n = 9 Pediatric

More information

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document

More information

:Connected care. Norfolk and Suffolk NHS Foundation Trust

:Connected care. Norfolk and Suffolk NHS Foundation Trust :Connected care Norfolk and Suffolk NHS Foundation Trust An off-the-shelf Therapeutic Drug Monitoring system developed by the NHS, for the NHS. Clinicians Hospital GP Nurse Practitioner Requesting Doctor

More information

Switching to Enterprise Drugs

Switching to Enterprise Drugs ................................................................................................... Switching to Enterprise Drugs Pharmacy Technology Solutions May, 2013 Filling New Prescriptions: Switching

More information

Potential Conflicts of Interests

Potential Conflicts of Interests Potential Conflicts of Interests Research Grants Agency for Healthcare Research and Quality Akers Bioscience, Inc. Pfizer, Inc. Scientific Advisory Boards Pfizer, Inc. Cadence Pharmaceuticals Kimberly

More information

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Implementation of Hematology- Oncology Education Program. Amir Steinberg, MD Samuel Oschin Comprehensive Cancer Center Cedars-Sinai Medical Center

Implementation of Hematology- Oncology Education Program. Amir Steinberg, MD Samuel Oschin Comprehensive Cancer Center Cedars-Sinai Medical Center Implementation of Hematology- Oncology Education Program Amir Steinberg, MD Samuel Oschin Comprehensive Cancer Center Cedars-Sinai Medical Center Cedars-Sinai Medical Center Large, tertiary care center

More information

Standing Orders Protocols Increase Adult Immunizations

Standing Orders Protocols Increase Adult Immunizations Standing Orders Protocols Increase Adult Immunizations William Atkinson, MD, MPH Associate Director for Immunization Education Immunization Action Coalition Saint Paul, Minnesota Immunization Action Coalition

More information

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro IV Vancomycin dosing and Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary Medicine Unique

More information

Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasiexperimental

Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasiexperimental Choe et al. BMC Infectious Diseases (2018) 18:178 https://doi.org/10.1186/s12879-018-3081-1 RESEARCH ARTICLE Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Measuring antimicrobial consumption: why, what and how? ESCMID Postgraduate Education Course Antimicrobial Stewardship Developing, Implementing & Measuring Seva (Barcelona), Spain, 8 10 May 2014 Håkan

More information

An Economic Framework to Inform the Scheduling of Medicines

An Economic Framework to Inform the Scheduling of Medicines An Economic Framework to Inform the Scheduling of Medicines Dr Bonny Parkinson Senior Research Fellow Centre for the Health Economy Dr Mutsa Gumbie Research Fellow Dr Henry Cutler Director Special thanks

More information

Drug use pattern with standard indicators in Jos University Teaching Hospital Nigeria. Henry C. Ndukwe, Ikoni J. Ogaji and Comfort N.

Drug use pattern with standard indicators in Jos University Teaching Hospital Nigeria. Henry C. Ndukwe, Ikoni J. Ogaji and Comfort N. West African Journal of Pharmacy (201) 24 (1) 88-9 Drug use pattern with standard indicators in Jos University Teaching Hospital Nigeria 1 2 1 Henry C. Ndukwe, Ikoni J. Ogaji and Comfort N. Sariem 1 Department

More information

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0 Consensus Core Set: ACO and PCMH / Primary Care s 0018 Controlling High Blood Pressure patients 18 to 85 years of age who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately

More information

Apatcha Pungjitprapai, M.D., Mattana Hanvanich, M.D. Abstract of Infectious Diseases Fellows

Apatcha Pungjitprapai, M.D., Mattana Hanvanich, M.D. Abstract of Infectious Diseases Fellows of Infectious Diseases Fellows A Study of Plasma HIV RNA Viral Load Response to the Treatment with Low Dose Stavudine (D4T) in Lamivudine (3TC) and Efavirenz Containing Highly Active Antiretroviral Regimen

More information

Definition. Synonyms 9/23/2010. Trials for which the hypothesis and study design are formulated based on information needed to make a decision

Definition. Synonyms 9/23/2010. Trials for which the hypothesis and study design are formulated based on information needed to make a decision Scott Ramsey, MD, PhD Definition Trials for which the hypothesis and study design are formulated based on information needed to make a decision Synonyms Pragmatic clinical trials Practical clinical trials

More information

Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure

Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure Journal of Medical Microbiology (2016), 65, 195 199 DOI 10.1099/jmm.0.000211 Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure Michael A. Lorenz, 1,2 Ryan P. Moenster

More information

Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital

Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital Final Results Nathan Beahm, BSP, PharmD(student) September 10, 2016 Objectives Review background information

More information

Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy. Pharmacists Role 1

Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy. Pharmacists Role 1 Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy Pharmacists Role 1 Promotion of health improvement, wellness, and disease prevention in cooperation

More information

Public Health Applications in Pharmacy

Public Health Applications in Pharmacy 1 Pharmacy 445 Public Health Applications in Pharmacy Jacqueline Gardner, Ph.D. Professor, Department of Pharmacy 2 Public or Community Health Distinct from clinical medicine, which focuses upon an individual

More information

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England The Infection Control Doctor and Clostridium difficile infection Dr David R Jenkins University Hospitals of Leicester NHS Trust, England 250 200 150 100 50 0 Monthly cases of Clostridium difficile (UHL

More information

Guideline for the Rational Use of Controlled Drugs

Guideline for the Rational Use of Controlled Drugs Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Conference For Healthcare Transparency & Patient Safety. Kraig Humbaugh, MD, MPH Lexington, KY November 13, 2015

Conference For Healthcare Transparency & Patient Safety. Kraig Humbaugh, MD, MPH Lexington, KY November 13, 2015 Conference For Healthcare Transparency & Patient Safety Kraig Humbaugh, MD, MPH Lexington, KY November 13, 2015 2 Objectives After this presentation, participants will be able to: Explain the importance

More information

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility Gerald A. Capraro, Ph.D., D(ABMM) Director, Clinical Microbiology Carolinas Pathology Group Atrium

More information

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe

Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe 26 April 2010 Proposals regarding the Cholesterol Lowering Pharmaceuticals Atorvastatin and Ezetimibe PHARMAC is seeking feedback on the following proposals relating to the cholesterol lowering pharmaceuticals

More information

Framework for Changing Drug Use Practices

Framework for Changing Drug Use Practices Framework for Changing Drug Use Practices 1 Framework for Changing Drug Use Practices: Objectives Identify specific drug use problems and place in perspective of underlying causes Identify 8-10 educational,

More information

Frequently Asked Questions: Pediatric Rehabilitation Medicine Review Committee for Physical Medicine and Rehabilitation ACGME

Frequently Asked Questions: Pediatric Rehabilitation Medicine Review Committee for Physical Medicine and Rehabilitation ACGME Frequently Asked Questions: Pediatric Rehabilitation Medicine Review Committee for Physical Medicine and Rehabilitation ACGME Question Institutions What are examples of close collaboration between the

More information

Prescription Drug Monitoring Program

Prescription Drug Monitoring Program California Department of Justice Prescription Drug Monitoring Program May, 2016 Health and Safety Code section 11165. (a) To assist health care practitioners in their efforts to ensure appropriate prescribing,

More information

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing ProMedica Health System Clinical Interdepartmental Policy and Procedure: Section: Policy: Date: Subject: Pharmacy Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

More information

Methodological Framework and Tools for Cross-National comparisons of Drug Utilization Data

Methodological Framework and Tools for Cross-National comparisons of Drug Utilization Data Methodological Framework and Tools for Cross-National comparisons of Drug Utilization Data Vander Stichele RH, MD, PhD Heymans Institute of Pharmacology, Ghent University, Belgium Summer School EACPT August

More information

Drug Utilization Review & Cost Reduction Strategies. Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources

Drug Utilization Review & Cost Reduction Strategies. Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources Drug Utilization Review & Cost Reduction Strategies Esther Liu, PharmD, MSIA, CGP Clinical Pharmacist Outcome Resources Goals and Objectives Define Drug Utilization Reviews Interpret various performance

More information

Justifying New Oncology Pharmacist Positions

Justifying New Oncology Pharmacist Positions Faculty Disclosures Justifying New Oncology Pharmacist Positions I will not be discussing off-label uses of any medications I am on the speaker s bureau for Millenium Pharmaceuticals and am a paid consultant

More information

Opioid epidemic and PEHP

Opioid epidemic and PEHP Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe

More information

London Medicines Information Service

London Medicines Information Service London Medicines Information Service Extended-release methylphenidate a review of the pharmacokinetic profiles available March 2018 First authored by Martin Bradley (martin.bradley@gstt.nhs.uk) May 2016

More information

Intensive Preceptorship Program in HIV/AIDS for Family Physicians and Nurse Practitioners

Intensive Preceptorship Program in HIV/AIDS for Family Physicians and Nurse Practitioners BC Centre for Excellence in HIV/AIDS Intensive Preceptorship Program in HIV/AIDS for Family Physicians and Nurse Practitioners Dr. Silvia A. Guillemi Director of Clinical Education, BC Centre for Excellence

More information

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist Intervention Study 2016 West ISD Gillian Ritchie Clinical Pharmacist Introduction Annual data collection Two weeks All Medicines Management Team interventions Details recorded Classified by type Outcomes

More information

LRI Children s Hospital

LRI Children s Hospital Title: Prescribing in Cystic Fibrosis Page 1 of 10 LRI Children s Hospital Prescribing in Cystic Fibrosis Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team & AWP approval

More information

Initiating Aminoglycosides Safely. Last updated: July 2016, Version 5 Questions/Comments?

Initiating Aminoglycosides Safely. Last updated: July 2016, Version 5 Questions/Comments? Initiating Aminoglycosides Safely Last updated: July 2016, Version 5 Questions/Comments? Email Mark.McIntyre@uhn.ca Click orange buttons to navigate protocol. Index: Aminoglycoside Dosing Algorithms Objective

More information

CLINICAL MICROBIOLOGY Haematopoietic Stem Cell Transplant & National Transplant Coordination

CLINICAL MICROBIOLOGY Haematopoietic Stem Cell Transplant & National Transplant Coordination Post CSCST Training in CLINICAL MICROBIOLOGY Haematopoietic Stem Cell Transplant & National Transplant Coordination Royal College of Physicians of Ireland, 2017 1 This curriculum of training in Haematopoietic

More information